National HealthCare Corp (NHC) company profile
Close on Nov 17, 2026Market cap $3.22BP/E 23.1Yield 1.23%
About National HealthCare
Services-Skilled Nursing Care Facilities, SIC 8051
National HealthCare Corporation provides post-acute and long-term healthcare services across multiple facility types and specialized programs. Its service offerings include skilled nursing, rehabilitative therapies, assisted and independent living, memory care, and behavioral health services. Through dedicated operating divisions, the company also delivers home healthcare visits and hospice care. In addition to direct clinical care, it operates regional institutional pharmacies and offers an Institutional Special Needs Plan Medicare Advantage product, while providing management, accounting, and insurance support services to third-party facility operators.
As of December 31, 2025, the company's network comprises 80 skilled nursing facilities, 26 assisted living communities, nine independent living facilities, and three behavioral health hospitals across owned, leased, and managed arrangements. It also operates 34 homecare agencies, 33 hospice branches, and five regional pharmacies, with operations across nine states primarily in the Southeastern and Midwestern United States. National HealthCare Corporation is headquartered in Murfreesboro, Tennessee.
Summary of the business section of National HealthCare's latest annual report, written by StockData.
Company profile
Company
- Legal name
- National HealthCare Corp
- Founded
- 1971
- Headquarters
- Murfreesboro, TN
- Address
- 100 E. Vine St 37130
- Phone
- (615) 890-2020
- Website
- nhccare.com
- Employees
- 15,278, Dec 31, 2025
- Industry
- Services-Skilled Nursing Care Facilities
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Nashville, Tennessee
Stock & identifiers
- Ticker
- NHC
- Exchange
- NYSE
- IPO date
- Jan 2, 1987
- Shares outstanding
- 16M, Aug 3, 2026
- Public float
- $900.60M, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1047335
- CUSIP
- 635906100
- ISIN
- US6359061008
- FIGI
- BBG000BY3T87
- Share class FIGI
- BBG001SBJ378
- LEI
- 254900PTS11LS1JS2752
- EIN
- 52-2057472
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Stephen Fowler Flatt | CEO, Director | 65,487 |
| Vicki L. Dodson | Sr.VP Patient Srvcs | 10,726 |
| Josh A. McCreary | Senior VP & General Counsel | 9,979 |
| Brian F. Kidd | SVP, CFO | 23,183 |
| Ben Anderson Flatt Sr | Senior VP & CIO | 15,636 |
| Timothy J. Shelly | Sr.VP Operations | 1,294 |
| Robert Michael Ussery | President & COO | 158,460 |
| David R. Gifford | Director | 1,030 |
| Emil E. Hassan | Director | 65,595 |
| Robert G. Adams | Director | 443,920 |
| Lisa Piercey | Director | 949 |
| Richard F. Laroche Jr | Director | 301,760 |
| Sandra Y. Trail | Director | 10,640 |
| William A. Adams | Director | – |
| James Paul Abernathy | Director | 43,302 |
| W. Andrew Adams | Director | 304,979 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $2.69M | $3.41M | $1.61M | $239 | $148 |
| FY2024 | $2.15M | $2.65M | $1.32M | $183 | $129 |
| FY2023 | $1.61M | $2.42M | $971.18K | $154 | $126 |
| FY2022 | $1.16M | $1.05M | $696.87K | $95 | $124 |
| FY2021 | $2.25M | $2.13M | $1.29M | $105 | $126 |
| FY2020 | $1.28M | $786.67K | $760.45K | $79 | $113 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| Stephen F. Flatt Chief Executive Officer | $577.00K | $505.22K | $300.48K | $1.28M | $22.67K | $2.69M | +25% |
| Brian F. Kidd SVP & Chief Financial Officer | $307.00K | $246.40K | $225.67K | $624.00K | $3.98K | $1.41M | +24% |
| B. Anderson Flatt SVP & Chief Information Officer | $270.00K | $219.42K | $226.71K | $556.00K | $19.94K | $1.29M | +24% |
| Josh A. McCreary SVP, General Counsel & Secretary | $301.00K | $238.38K | $225.36K | $604.00K | $4.27K | $1.37M | +22% |
| R. Michael Ussery President & Chief Operating Officer (Retired) | $521.00K | $446.85K | $250.40K | $1.13M | $31.93K | $2.38M | +19% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 15,278 full-time and part-time employees (“partners”), mainly through our Administrative Services Contractor (National Health Corporation).”
Corporate history
Events identified from SEC filings
See a number that looks wrong?